These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33633136)
1. Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome. Metselaar PI; Mendoza-Maldonado L; Li Yim AYF; Abarkan I; Henneman P; Te Velde AA; Schönhuth A; Bosch JA; Kraneveld AD; Lopez-Rincon A Sci Rep; 2021 Feb; 11(1):4541. PubMed ID: 33633136 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC; Herrera S; Vernon SD; McGowan PO BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836 [TBL] [Abstract][Full Text] [Related]
3. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients. Cheng Y; Xu SM; Takenaka K; Lindner G; Curry-Hyde A; Janitz M Gene; 2023 Aug; 877():147568. PubMed ID: 37328077 [TBL] [Abstract][Full Text] [Related]
4. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions. Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325 [TBL] [Abstract][Full Text] [Related]
5. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681 [TBL] [Abstract][Full Text] [Related]
6. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns. Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399 [TBL] [Abstract][Full Text] [Related]
7. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648 [TBL] [Abstract][Full Text] [Related]
8. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME). Petty RD; McCarthy NE; Le Dieu R; Kerr JR PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895 [TBL] [Abstract][Full Text] [Related]
10. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Nelson MJ; Buckley JD; Thomson RL; Clark D; Kwiatek R; Davison K J Transl Med; 2019 Mar; 17(1):80. PubMed ID: 30871578 [TBL] [Abstract][Full Text] [Related]
12. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Bested AC; Marshall LM Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325 [TBL] [Abstract][Full Text] [Related]
14. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Yamano E; Watanabe Y; Kataoka Y Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365 [TBL] [Abstract][Full Text] [Related]
15. Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Herrera S; de Vega WC; Ashbrook D; Vernon SD; McGowan PO Epigenetics; 2018; 13(12):1174-1190. PubMed ID: 30516085 [TBL] [Abstract][Full Text] [Related]
16. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
18. A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy. Xu J; Potter M; Tomas C; Elson JL; Morten KJ; Poulton J; Wang N; Jin H; Hou Z; Huang WE Analyst; 2019 Jan; 144(3):913-920. PubMed ID: 30207334 [TBL] [Abstract][Full Text] [Related]